{"id":278568,"date":"2020-12-14T06:47:16","date_gmt":"2020-12-14T11:47:16","guid":{"rendered":"https:\/\/canadianinquirer.net\/v1\/?p=278568"},"modified":"2020-12-14T06:47:16","modified_gmt":"2020-12-14T11:47:16","slug":"recruitment-of-avigan-trial-participants-ongoing-doh","status":"publish","type":"post","link":"https:\/\/canadianinquirer.net\/v1\/2020\/12\/14\/recruitment-of-avigan-trial-participants-ongoing-doh\/","title":{"rendered":"Recruitment of Avigan trial participants ongoing: DOH"},"content":{"rendered":"<figure id=\"attachment_264391\" aria-describedby=\"caption-attachment-264391\" style=\"width: 1280px\" class=\"wp-caption alignnone\"><a href=\"https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2020\/08\/medications-257349_1280.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-264391\" src=\"https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2020\/08\/medications-257349_1280.jpg\" alt=\"\" width=\"1280\" height=\"847\" srcset=\"https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2020\/08\/medications-257349_1280.jpg 1280w, https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2020\/08\/medications-257349_1280-300x199.jpg 300w, https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2020\/08\/medications-257349_1280-768x508.jpg 768w, https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2020\/08\/medications-257349_1280-1024x678.jpg 1024w\" sizes=\"auto, (max-width: 1280px) 100vw, 1280px\" \/><\/a><figcaption id=\"caption-attachment-264391\" class=\"wp-caption-text\">Vergeire reported that the recruitment of trial participants is ongoing as it requires the involvement of more than 100 people. (Pixabay photo)<\/figcaption><\/figure>\n<p><strong>MANILA<\/strong>\u00a0\u2013 The government continues to recruit participants for the Avigan clinical trials in the country, a health official said Monday.<\/p>\n<p>&#8220;As of Dec. 7,\u00a0<em>may<\/em>\u00a016 participants\u00a0<em>na na<\/em>-recruit,\u00a0<em>na<\/em>-screen\u00a0<em>at na<\/em>-enroll\u00a0<em>dun sa<\/em>\u00a0study.\u00a0<em>Mayroon tayong<\/em>\u00a0nine active participants\u00a0<em>kung saan<\/em>\u00a0(There are 16 recruited participants, [they] were screened and enrolled to the study. There are nine active participants, of which,) five have already completed the trial while two have withdrawn,&#8221; Health Undersecretary Maria Rosario Vergeire said during an online media forum.<\/p>\n<p>Japan&#8217;s anti-flu drug Avigan is considered a potential treatment against coronavirus disease 2019 (Covid-19).<\/p>\n<p>Vergeire reported that the recruitment of trial participants is ongoing as it requires the involvement of more than 100 people.<\/p>\n<p>In November, the protocol requirements in enrolling trial participants have been eased to enlist more people in Avigan clinical trials in the country.<\/p>\n<p>The revised protocol allowed the participation of patients with Covid-19, those classified with or without pneumonia, and not on high-flow oxygen support.<\/p>\n<p>&#8220;<em>Ang<\/em>\u00a0study sites\u00a0<em>natin ngayon<\/em>\u00a0(Our study sites now) like what we&#8217;ve mentioned previously Philippine General Hospital, Quirino Memorial Medical Center, Jose N. Reyes Memorial Hospital and Santa Ana Hospital,&#8221; Vergeire said.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>MANILA\u00a0\u2013 The government continues to recruit participants for the Avigan clinical trials in the country, a health official said Monday. &hellip;<\/p>\n","protected":false},"author":33,"featured_media":264391,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16,95],"tags":[],"class_list":["post-278568","post","type-post","status-publish","format-standard","has-post-thumbnail","category-news","category-news-ph","mauthors-ma-teresa-montemayor","mauthors-philippine-news-agency"],"_links":{"self":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/278568","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/users\/33"}],"replies":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/comments?post=278568"}],"version-history":[{"count":1,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/278568\/revisions"}],"predecessor-version":[{"id":278578,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/278568\/revisions\/278578"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/media\/264391"}],"wp:attachment":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/media?parent=278568"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/categories?post=278568"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/tags?post=278568"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}